Navigation Links
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Date:2/10/2009

acterial exacerbations in patients with cystic fibrosis and COPD. The company has also built a discovery and development platform and intellectual property estate around inhibitors of multi-drug resistant (MDR) efflux pumps (EPIs) found in many gram-negative bacterial pathogens. Bacterial efflux of antibiotics is a leading source of multi-drug resistance, particularly in gram-negative organisms. Mpex compounds have been shown in both in vitro and in vivo studies to overcome efflux-based resistance to multiple classes of antibiotics. In 2008 Mpex entered into a collaboration with GlaxoSmithKline focused on developing multiple drug candidates utilizing Mpex's EPI technology. Company website: www.mpexpharma.com.

About Investor Growth Capital

Investor Growth Capital (IGC) is the wholly-owned venture capital arm of Investor AB, a publicly traded industrial holding company, listed on the Stockholm Exchange. IGC was formed in the mid-1990s to invest in high quality, growth oriented companies, primarily in the Healthcare and IT industries. Today its 30 investment professionals are developing a portfolio whose value exceeds $850 million from offices located in New York, Menlo Park, Stockholm, Hong Kong, Tokyo and Beijing. For almost a century Investor AB's business philosophy has been to build best-in-class companies in sectors where the group has strong knowledge and a networking advantage. IGC shares that approach and benefits from Investor AB's extensive global network of companies and senior managers. For more information, visit www.investorgrowthcapital.com.

About RiverVest Venture Partners

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
2. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
3. Pharmaceuticals sold in Sweden cause serious environmental harm in India
4. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
5. Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results
6. Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
8. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
10. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015 Attorney Dan Newlin, of the ... protecting his clients, took that commitment to a whole new ... which makes it easier for existing and potential clients to ... his brand and added value to the firm’s services, #Dan ... where Newlin has law offices. , “I knew the pound ...
(Date:4/27/2015)... The Global Pharmaceutical Packaging Market 2015 ... of 5.9% during the period 2015 – 2019. Plastics ... healthcare packaging market, mainly due to their cost effectiveness ... is extremely fragmented with the presence of several ... the market with the rest being occupied by several ...
(Date:4/27/2015)... Puroast Coffee has signed on to sponsor the BattleFrog ... OCR is a series of rigorous courses designed by U.S. ... training that Seals undergo, as well as provide a fun, ... sponsor the BattleFrog events this year,” says Puroast CEO Kerry ... to give people throughout the country the chance to try ...
(Date:4/27/2015)... Consumer Choice Award is thrilled ... respective sectors for Ottawa. We would like to extend ... to superior service has resonated with the people of ... gathers opinions, perceptions and expectations through the responses of ... through a rigorous selection process conducted by a third ...
(Date:4/27/2015)... 2015 The WeedLife Network has ... problem that has been troubling cannabis businesses with ... by announcing the launch of WeedLIVE, the first-ever ... , Officially launched today, WeedLIVE.com is designed specifically ... index only marijuana-related business websites. , WeedLIVE deals ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Puroast Coffee on Tour with BattleFrog 2Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 3
... MLAB ) today reported significantly higher sales and earnings for both its fiscal ... , Third quarter revenue ... income increases 8% , Third quarter ... For the third quarter of fiscal 2009, net sales increased 16 percent to $5,337,000 ...
... 2009 Revenue and EPS Guidance , BETHESDA, Md., Feb. 10 ... announced net sales of $185.5 million for the quarter ended ... from $170.8 million in the prior year,s comparable quarter. ... in the fourth quarter 2008 from $10.0 million in the ...
... ... Harrisburg, PA (PRWEB) February 10, 2009 -- KePRO ... Hanley as Business Development Director, Public Programs. He will be responsible ... revenue. , , , , ,"Shawn brings over 10 years ...
... you stop taking the drug, study finds , , TUESDAY, Feb. ... other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to reduce the risk ... That,s the conclusion of a new study of people at ... arguably proven, that NSAID drugs do interfere with the development ...
... that youth will engage in substance use can be neutralized by high ... Georgia study. , ... Athens, Ga. (PRWEB) February 10, 2009 -- A ... substance use can be neutralized by high levels of involved and supportive ...
... A genetic risk factor that increases the likelihood that ... high levels of involved and supportive parenting, according to a ... the February issue of the Journal of Consulting and ... of youth over time to see how a genetic risk ...
Cached Medicine News:Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 9Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 10Health News:Shawn Hanley Named KePRO Director of Business Development - Public Programs 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 2Health News:Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions 3Health News:Study: Genetic Risk for Substance Use Can be Neutralized by Good Parenting 2Health News:Study: Genetic Risk for Substance Use Can be Neutralized by Good Parenting 3Health News:Study: Genetic risk for substance use can be neutralized by good parenting 2
(Date:4/27/2015)... China Jo-Jo Drugstores, Inc. (NASDAQ ... a leading China-based retail and wholesale distributor that offers ... retail pharmacies, today announced its subsidiary, Hangzhou Jiuzhou Grand ... new sales incentive agreement with Wyeth Pharmaceutical Company, Ltd. ... of Pfizer Inc. (NYSE: PFE ) ...
(Date:4/26/2015)... April 26, 2015  Ikonopedia announced today that ... system have been selected for use by BelleBridge, ... screening and diagnostic examinations. Ikonopedia will showcase its ... of Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... 2015 (SBI Booth #216). BelleBridge is ...
(Date:4/24/2015)... -- Today, humanity takes a massive step toward reaching our ... 1-800 CONTACTS announces their new Apple Watch app which allows ... Two taps. New contacts. From your watch. We ... features LensGauge which helps keep track of how long your ... "Since our inception, we,ve been dedicated to providing ...
Breaking Medicine Technology:China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2
... , May 25 Otix Global, Inc. (Nasdaq: ... has begun offering franchising opportunities to audiologists and audiometrists throughout ... at the annual Audiological Society of Australia (ASA) conference ... to the American Academy of Audiology conference which is held in ...
... CAMPBELL, Calif. , May 25 ... and personalized therapy guidelines for cardiovascular disease.  HNL ... offering an accompanying nutrition program, and wellness coaching. ... appropriate risk characterization and treatment, cardiovascular disease can ...
Cached Medicine Technology:Otix Global to Offer Franchise Opportunities in Australia 2Otix Global to Offer Franchise Opportunities in Australia 3Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2
... pressure sensor catheters incorporate a ... injection/guide wire, or high-speed injection/guide ... high-speed injection has two laterally ... an open-end pigtail extension for ...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
... dBC is a flat detector biplane ... ideal for cardiological diagnostics and intervention. ... you to optimally adapt the system ... and electrophysiological applications with tableside operation. ...
Medicine Products: